MAPT and neurodegenerative disease: Recently, based on tau‐targeted exogenous contrast agent, tau protein imaging in the whole mice brain was achieved via MSOT, which had potential use in detecting tau spreading and clearance in tauopathy‐related neurodegenerative diseases.21